&w=3840&q=100)
BHISHM medical cubes deployed in J&K hospitals under Aarogya Maitri project
The development comes on the heels of Union Health Minister J P Nadda on Friday reviewing health infrastructure preparedness across hospitals in the country amid the ongoing Operation Sindoor and the ongoing India-Pakistan military conflict, official sources said.
These BHISHM cubes are also being stationed in other Institutes of National Importance (INIs) across India, including AIIMS in Rishikesh, Bilaspur and Delhi, they said.
"We are also providing operational training to the respective medical institutes where BHISHM cubes have been deployed. So far two BHISHM cubes have been deployed at AIIMS, Jammu and more are being diverted to this centre.
"Besides, around 35 other BHISHM cubes so far have been deployed across other Institutes of National Importance (INIs) across India," said Air Vice Marshal Dr Tanmoy Roy, HLL Lifecare.
Dr Roy said HLL Life Care Ltd under the Union Health Ministry is the nodal agency for the procurement and deployment of Aarogya Maitri Cube.
BHISHM cubes are portable and rapidly deployable modular medical facilities to provide emergency lifesaving clinical care in the event of disaster or public health emergencies.
Each cube is equipped with medicines and surgical equipment for basic operations, and it has the capacity to handle around 200 diverse emergency cases.
The cube comprises 72 easily transportable components, designed for versatile delivery methods including hand-carry, bicycle or even drone transport.
The aid cube is equipped with several innovative tools designed to enhance disaster response and medical support during emergencies. It integrates Artificial Intelligence (AI) and data analytics to facilitate effective coordination, real-time monitoring and efficient management of medical services in the field.
Being robust, waterproof and lightweight, the cubes are also built to withstand harsh conditions. Their flexible configuration allows deployment in diverse emergency scenarios. The system can be quickly dispatched via airdrop or ground transportation, ensuring swift response to crises anywhere.
In the wake of Operation Sindoor, Prime Minister Narendra Modi on Thursday chaired a high-level meeting with secretaries of various ministries and called for continued alertness and clear communication, while reaffirming the government's commitment to national security and operational preparedness.
The Indian armed forces are on high alert in the wake of the current hostilities between New Delhi and Islamabad following the Pahalgam terrorist attack of April 22 and India's strike on terror targets in Pakistan and Pakistan-occupied Kashmir (PoK) in retaliation.
Pakistani forces are targetting border areas on the Indian side, killing at least 13 people and injuring others.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Covid vaccine & Karnataka's recent cardiac deaths not linked, finds Jayadeva Institute report
Bengaluru: A state govt-backed study into the alarming rise in sudden cardiovascular events (including heart attacks and cardiac deaths) among youngsters has concluded that Covid-19 vaccination isn't linked to the fatalities. The study categorically states: "There is no single cause behind the observed rise in sudden cardiac deaths; it appears to be a multi-factorial issue with behaviour, genetic and environmental risks." Commissioned by the Siddaramaiah govt and readied by Jayadeva Institute of Cardiovascular Sciences and Research director Dr KS Ravindranath, the sudy follows growing public concern over anecdotal reports of heart attacks and sudden deaths, especially among individuals under 45 years of age, in the state in the post-pandemic era. This multi-disciplinary effort — led by cardiologists, public health experts, virologists and epidemiologists — synthesised national and international data, and included a pilot study of 251 patients admitted to Jayadeva hospital with coronary artery disease between April 1 and May 31 this year. The findings were clear: No evidence was found linking Covid-19 vaccination and increased risk of premature cardiovascular disease. On the contrary, Indian and international studies reviewed by the expert panel suggested that Covid vaccines, particularly inactivated and mRNA platforms, are associated with lower odds of sudden cardiac death. The study also emphasised that most vaccine-related cardiac complications reported globally were rare, self-limiting, and significantly less severe than those caused by the actual Covid-19 infection. You Can Also Check: Bengaluru AQI | Weather in Bengaluru | Bank Holidays in Bengaluru | Public Holidays in Bengaluru Out of the 251 patients studied, nearly all (249) had been vaccinated, with 72% having received two doses and 57% having taken Covishield — the most common vaccine administered in the country. Only 19 patients (7.6%) reported a history of Covid infection, which could be an effect of recall bias (when the survey participant's ability to accurately remember past events becomes flawed over time) or a pointer to the high rate of asymptomatic infections in the population. Effect of lifestyle changes A comparison with pre-pandemic data from 2019 showed a modest rise in conventional cardiac risk factors such as diabetes, hypertension and cholesterol disorders, indicating that lifestyle changes during the pandemic period may be driving the increased cardiovascular burden rather than the virus or the vaccine. The data shows while Covid-19 infection can cause inflammation and clotting abnormalities that increase short-term cardiac risk, there's no scientific evidence to support long-term increased risk due to vaccination. It instead attributes the trend to multiple causes, including rising metabolic disorders, sedentary lifestyles, poor diet, and substance abuse among youngsters.
Time of India
3 hours ago
- Time of India
Antibiotic developed in India proves effective against complicated UTI: Top expert
1 2 3 Pune: An indigenously developed antibiotic has emerged as a "blessing" in the treatment of complicated urinary tract infections (UTIs) among Indian patients, said Dr V Balaji, professor of clinical microbiology at Christian Medical College (CMC), Vellore. Dr Balaji, also a key member of the Indian Network for Surveillance of Antimicrobial Resistance (INSAR) Network, was speaking in Pune at the 13th annual international Best of Brussels symposium on intensive care and emergency medicine held on Saturday. More than 700 critical-care specialists are attending the three-day conference, which began on Friday. About the antibiotic — called cefepime-enmetazobactam — Dr Balaji said it has shown to be "highly effective", especially for treating complicated UTIs. Cefepime-enmetazobactam was fully developed in India, right from conception to trial phases. You Can Also Check: Pune AQI | Weather in Pune | Bank Holidays in Pune | Public Holidays in Pune Dr Balaji said: "Till now, no new drug was ever discovered in India, against cancer, hypertension, diabetes or even antibiotics. But for the first time, chemists in Chennai discovered a new antibiotic called cefepime-enmetazobactam. This is a big achievement because usually, when a drug is discovered abroad, it takes 5–6 years to reach India. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo And when it comes to India, it's 3–5 times more expensive." He added that since the drug discovery was in India, it was released here first at one-tenth of the cost. "It's highly effective and affordable, especially for treating complicated UTIs," he said. At the symposium, doctors also discussed irrational use of antibiotics. They said that in addition to misuse of antibiotics, use of unchecked generic medicines that were freely available in the market was triggering AMR in complicated UTIs. Dr Shirish Prayag, organising chairperson of the symposium and a leading intensivist from Pune, said: "Complicated UTIs are the most common bacterial infections in India. According to WHO, bacterial AMR is directly responsible for nearly 12 lakh deaths worldwide and indirectly responsible for 49 lakh deaths. E. coli and Klebsiella pneumoniae are the most common causes of complicated UTIs. Patients with complicated UTIs, if left untreated, may require surgeries, renal replacement, utmost intensive care and even ventilation that prolongs hospitalisation. " Dr Kapil Zirpe, organizing secretary of the symposium, said: "When E. coli and other pathogens become resistant to anti-infectives like carbapenem, it is termed as carbapenem-resistant Enterobacterales (CRE). In India, mortality associated with CRE infections is as high as 20% to 54.3%, thus underscoring need for newer treatment options. Broad-spectrum antibiotics should not be used if a patient's vitals are fine. In such cases, a moderate-spectrum antibiotic is fine." Dr Subhal Dixit, joint organising secretary of the symposium, said antibiotics should be started only after proper collection of culture. "Antibiotics should always be used cautiously, only with a proper prescription and strictly based on a culture sensitivity–guided protocol."
The Hindu
5 hours ago
- The Hindu
Experts from various countries join IIRSI 2025 ophthalmology convention in Chennai
The two-day Indian Intraocular Implant & Refractive Surgery Convention 2025 (IIRSI Convention), the annual flagship event of Intraocular Implant & Refractive Society of India, was inaugurated on Saturday in the city. The convention was launched by Anil Kumar Bachoo, Minister of Health & Wellness, Government of Mauritius, Palanivel Thiaga Rajan, Minister for Information Technology and digital Services, Government of Tamil Nadu, and Arthi Ganesh, Pro-Chancellor, Vels University. Led by Satanshu Mathur, President, IIRSI, alongside Amar Agarwal, Secretary General, IIRSI, and Mahipal S. Sachdev, Chairman Scientific Committee-IIRSI, the convention attracted over 1,000 ophthalmologists, surgeons, researchers, and experts from around the world. The event featured foreign faculty lectures, live surgery, hands-on wet lab focussing on cataract, refractive and intraocular implantation. At the inauguration, Mr. Bachoo highlighted Mauritius' commitment to free and universal eye care, its public health system, international collaborations, and ongoing efforts to build local ophthalmic capacity. He expressed gratitude to Indian medical institutions, especially those in Chennai, for their important role in treating complex cases and supporting Mauritius through training and specialised care. Stephen McLeod, CEO of the American Academy of Ophthalmology, received a gold medal in recognition of his contributions to the field of ophthalmology. Several other individuals were also honored with awards. Ophthalmic experts Gaurav Luthra, Mohan Rajan, Rohit Om Prakash, Ragini Parekh were present.
